Citations

Gupta, R. K, J. Gregson, N. Parkin, H. Haile-Selassie, A. Tanuri, L. Andrade Forero, P. Kaleebu, C. Watera, A. Aghokeng, N. Mutenda, J. Dzangare, S. Hone, Z. Z Hang, J. Garcia, Z. Garcia, P. Marchorro, E. Beteta, A. Giron, R. Hamers, R. Inzaule, L. M Frenkel, M. H Chung, T. de Oliveira, D. Pillay, K. Naidoo, A. Kharsany, R. Kugathasan, T. Cutino, G. Hunt, S. Avila Rios, M. Doherty, M. R Jordan, and S. Bertagnolio. "HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis." Lancet Infect Dis 18, no. 3 (2018): 346-355.

Tostevin, A., E. White, D. Dunn, S. Croxford, V. Delpech, I. Williams, D. Asboe, A. Pozniak, D. Churchill, A. M Geretti, D. Pillay, C. Sabin, A. Leigh-Brown, E. Smit, and Uk Hiv Drug Resistance Database. "Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom." HIV Med 18, no. 3 (2017): 204-213.

El Bouzidi, K., E. White, J. L Mbisa, C. A Sabin, A. N Phillips, N. Mackie, A. L Pozniak, A. Tostevin, D. Pillay, D. T Dunn, Uk Hiv Drug Resistance Database, and the, U. K. Collaborative H. I. V. Cohort Study Steering Committees, Uk Hiv Drug Resistance Database, and the, U. K. Collaborative H. I. V. Cohort Study Steering Committees. "HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK." J Antimicrob Chemother 71, no. 12 (2016): 3487-3494.

Phillips, A. N, V. Cambiano, F. Nakagawa, P. Revill, M. R Jordan, T. B Hallett, M. Doherty, A. De Luca, J. D Lundgren, M. Mhangara, T. Apollo, J. Mellors, B. Nichols, U. Parikh, D. Pillay, T. Rinke de Wit, K. Sigaloff, D. Havlir, D. R Kuritzkes, A. Pozniak, D. van de Vijver, M. Vitoria, M. A Wainberg, E. Raizes, S. Bertagnolio, and Working Group on Modelling Potential Responses to High Levels of Pre, A. R. T. Drug Resistance in Sub-Saharan Africa. "Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study." Lancet HIV 5, no. 3 (2018): e146-e154.

Gregson, J., P. Kaleebu, V. C Marconi, C. van Vuuren, N. Ndembi, R. L Hamers, P. Kanki, C. J Hoffmann, S. Lockman, D. Pillay, T. de Oliveira, N. Clumeck, G. Hunt, B. Kerschberger, R. W Shafer, C. Yang, E. Raizes, R. Kantor, and R. K Gupta. "Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study." Lancet Infect Dis 17, no. 3 (2017): 296-304.

Lippman, S. A, A. C Mooney, A. Puren, G. Hunt, J. S Grignon, L. M Prach, H. J Gilmore, H. M Truong, S. Barnhart, and T. Liegler. "The role of drug resistance in poor viral suppression in rural South Africa: findings from a population-based study." BMC Infect Dis 20, no. 1 (2020).

de Welzen, L., V. Eldholm, K. Maharaj, A. L Manson, A. M Earl, and A. S Pym. "Whole-Transcriptome and -Genome Analysis of Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates Identifies Downregulation of ethA as a Mechanism of Ethionamide Resistance." Antimicrob Agents Chemother 61, no. 12 (2017).

Audet, C. M, B. E Shepherd, M. H Aliyu, M. Moshabela, M. J Pettapiece-Phillips, and R. G Wagner. "HIV drug resistance levels in adults failing first-line antiretroviral therapy in an urban and a rural setting in South Africa." HIV Med 18, no. 2 (2017): 104-114.

Manson, A. L, K. A Cohen, T. Abeel, C. A Desjardins, D. T Armstrong, C. E Barry, J. Brand, T. BResist Global Genome Consortium, S. B Chapman, S. N Cho, A. Gabrielian, J. Gomez, A. M Jodals, M. Joloba, P. Jureen, J. S Lee, L. Malinga, M. Maiga, D. Nordenberg, E. Noroc, E. Romancenco, A. Salazar, W. Ssengooba, A. A Velayati, K. Winglee, A. Zalutskaya, L. E Via, G. H Cassell, S. E Dorman, J. Ellner, P. Farnia, J. E Galagan, A. Rosenthal, V. Crudu, D. Homorodean, P. R Hsueh, S. Narayanan, A. S Pym, A. Skrahina, S. Swaminathan, M. Van der Walt, D. Alland, W. R Bishai, T. Cohen, S. Hoffner, B. W Birren, and A. M Earl. "Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance." Nat Genet 49, no. 3 (2017): 395-402.

Smit, E., E. White, D. Clark, D. Churchill, Z. Zhang, S. Collins, D. Pillay, C. Sabin, M. Nelson, A. Winston, S. Jose, A. Tostevin, D. T Dunn, Uk Hiv Drug Resistance Database, and the, U. K. Collaborative H. I. V. Cohort. "An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs." J Antimicrob Chemother 72, no. 7 (2017): 2075-2082.

Nkonki, L., A. Tugendhaft, and K. Hofman. "A systematic review of economic evaluations of CHW interventions aimed at improving child health outcomes." Hum Resour Health 15, no. 1 (2017).

Ngcapu, S., K. Theys, P. Libin, V. C Marconi, H. Sunpath, T. Ndung'u, and M. L Gordon. "Characterization of Nucleoside Reverse Transcriptase Inhibitor-Associated Mutations in the RNase H Region of HIV-1 Subtype C Infected Individuals." Viruses 9, no. 11 (2017).

Schultze, A., R. Paredes, C. Sabin, A. N Phillips, D. Pillay, N. Mackie, A. Castagna, D. Chadwick, K. Falconer, A. M Geretti, F. A Post, T. Hill, O. Kirk, A. Pozniak, M. Nelson, A. Tostevin, D. Dunn, J. Lundgren, and A. Cozzi-Lepri. "The association between detected drug resistance mutations and CD4(+) T-cell decline in HIV-positive individuals maintained on a failing treatment regimen." Antivir Ther 23, no. 2 (2018): 105-116.

Zhukova, A., T. Cutino-Moguel, O. Gascuel, and D. Pillay. "The Role of Phylogenetics as a Tool to Predict the Spread of Resistance." J Infect Dis 216, no. suppl_9 (2017): S820-S823.

Yadon, A. N, K. Maharaj, J. H Adamson, Y. Lai, J. C Sacchettini, T. R Ioerger, E. J Rubin, and A. S Pym. "A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide." Nature Communications 8, no. 1 (2017).

Etoori, D., A. Wringe, C. W Kabudula, J. Renju, B. Rice, F. X Gomez-Olive, and G. Reniers. "Misreporting of Patient Outcomes in the South African National HIV Treatment Database: Consequences for Programme Planning, Monitoring, and Evaluation." (2020) Front Public Health.

Willcox, M. L, J. Price, S. Scott, B. D Nicholson, B. Stuart, N. W Roberts, H. Allott, V. Mubangizi, A. Dumont, and A. Harnden. "Death audits and reviews for reducing maternal, perinatal and child mortality." (2020) Cochrane Database Syst Rev.

Abeler-Dorner, L., M. K Grabowski, A. Rambaut, D. Pillay, C. Fraser, and Pangea consortium. "PANGEA-HIV 2: Phylogenetics And Networks for Generalised Epidemics in Africa." Curr Opin HIV AIDS 14, no. 3 (2019): 173-180.

Goodall, R. L, D. T Dunn, P. Nkurunziza, L. Mugarura, T. Pattery, P. Munderi, C. Kityo, C. Gilks, P. Kaleebu, D. Pillay, R. K Gupta, and Dart Virology Group. "Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa." J Antimicrob Chemother 72, no. 5 (2017): 1450-1455.

McCluskey, S. M, T. Pepperrell, A. Hill, W. D. F Venter, R. K Gupta, and M. J Siedner. "Adherence, resistance, and viral suppression on dolutegravir in sub-Saharan Africa: implications for the TLD era." AIDS 35, no. Supplement 2 (2021): S127-S135.

Kim, H. Y, G. Harling, A. Vandormael, A. Tomita, D. F Cuadros, T. Barnighausen, and F. Tanser. "HIV seroconcordance among heterosexual couples in rural KwaZulu-Natal, South Africa: a population-based analysis." J Int AIDS Soc 23, no. 1 (2020).

Laher, F., S. Ranasinghe, F. Porichis, N. Mewalal, K. Pretorius, N. Ismail, S. Buus, A. Stryhn, M. Stryhn, B. D Walker, T. Ndung'u, and Z. M Ndhlovu. "HIV Controllers Exhibit Enhanced Frequencies of Major Histocompatibility Complex Class II Tetramer(+) Gag-Specific CD4(+) T Cells in Chronic Clade C HIV-1 Infection." J Virol 91, no. 7 (2017).

Ortblad, K., D. Kibuuka Musoke, T. Ngabirano, A. Nakitende, J. Magoola, P. Kayiira, G. Taasi, L. G Barresi, J. E Haberer, M. A McConnell, C. E Oldenburg, and T. Barnighausen. "Direct provision versus facility collection of HIV self-tests among female sex workers in Uganda: A cluster-randomized controlled health systems trial." PLoS Med 14, no. 11 (2017).

Titanji, B. K, D. Pillay, and C. Jolly. "Combination antiretroviral therapy and cell-cell spread of wild-type and drug-resistant human immunodeficiency virus-1." J Gen Virol 98, no. 4 (2017): 821-834.

Iwuji, C. C, M. Shahmanesh, O. Koole, K. Herbst, D. Pillay, M. J Siedner, K. Baisley, and H. Dream Network. "Clinical outcomes after first-line HIV treatment failure in South Africa: the next cascade of care." HIV Med 21, no. 7 (2020).

Shangase, N., B. Pence, S. A Lippman, M. K Dufour, C. W Kabudula, F. X Gomez-Olive, K. Kahn, and A. Pettifor. "Built Environment and HIV Linkage to Care in Rural South Africa." (2021) Int Q Community Health Educ.

Vandormael, A., F. Rego, S. Danaviah, L. Carlos Junior Alcantara, D. R Boulware, and T. de Oliveira. "CD4+ T-cell Count may not be a Useful Strategy to Monitor Antiretroviral Therapy Response in HTLV-1/HIV Co-infected Patients." Curr HIV Res 15, no. 3 (2017): 225-231.

Bocquier, P., C. Ginsburg, K. Herbst, O. Sankoh, and M. A Collinson. "A training manual for event history data management using Health and Demographic Surveillance System data." BMC Res Notes 10, no. 1 (2017).

Kariuki, S. M, A. Abubakar, M. Kombe, M. Kazungu, R. Odhiambo, A. Stein, and Crjc Newton. "Burden, risk factors, and comorbidities of behavioural and emotional problems in Kenyan children: a population-based study." Lancet Psychiatry 4, no. 2 (2017): 136-145.

Cumming, B. M, K. C Chinta, V. P Reddy, and A. J C Steyn. "Role of Ergothioneine in Microbial Physiology and Pathogenesis." Antioxid Redox Signal 2018, no. 6 (2018): 431-444.